首页 > 最新文献

Frontiers in Medicine最新文献

英文 中文
Revisiting Janus kinases as molecular drug targets for rheumatic diseases. 再论Janus激酶作为风湿病的分子药物靶点。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1716179
Sunghark Kwon

Janus kinase (JAK) family members, as upstream regulators, phosphorylate not only themselves but also cytokine receptors and signal transducer and activator of transcription (STAT) proteins in the JAK-STAT signaling pathway. The JAK-STAT pathway is associated with various cellular processes, such as cell proliferation, cell death, and immune responses. Considering that the JAK-STAT pathway is involved in immunity, dysfunctional JAKs can cause autoimmune diseases, including rheumatoid arthritis. Therefore, several inhibitors have been developed to inhibit the function of JAKs in the case of abnormal JAK-STAT signaling. Emerging structural data on JAKs highlight the opportunities to design selective inhibitors that can overcome mutation-driven resistance. Therefore, novel JAK inhibitors need to be developed. In this review, we discuss the principal structural features of JAKs, focusing on the active site. In addition, we summarized the updated JAK inhibitors indicated for rheumatoid arthritis that are available in the pharmaceutical market. The binding modes of JAK inhibitors have also been described. Based on the structural analysis of JAKs and their inhibitors, we propose strategies for developing next-generation JAK inhibitors.

Janus kinase (JAK)家族成员作为上游调控因子,在JAK-STAT信号通路中不仅磷酸化自身,还磷酸化细胞因子受体和转录激活因子(signal transducer and activator of transcription, STAT)蛋白。JAK-STAT通路与多种细胞过程相关,如细胞增殖、细胞死亡和免疫应答。考虑到JAK-STAT通路参与免疫,功能失调的jak可引起自身免疫性疾病,包括类风湿关节炎。因此,已经开发了几种抑制剂来抑制JAK-STAT信号异常情况下jak的功能。关于jak的新结构数据强调了设计选择性抑制剂来克服突变驱动抗性的机会。因此,需要开发新的JAK抑制剂。在这篇综述中,我们讨论了jak的主要结构特征,重点是活性位点。此外,我们总结了制药市场上可用的用于类风湿性关节炎的最新JAK抑制剂。JAK抑制剂的结合模式也被描述。基于JAK及其抑制剂的结构分析,我们提出了下一代JAK抑制剂的开发策略。
{"title":"Revisiting Janus kinases as molecular drug targets for rheumatic diseases.","authors":"Sunghark Kwon","doi":"10.3389/fmed.2026.1716179","DOIUrl":"https://doi.org/10.3389/fmed.2026.1716179","url":null,"abstract":"<p><p>Janus kinase (JAK) family members, as upstream regulators, phosphorylate not only themselves but also cytokine receptors and signal transducer and activator of transcription (STAT) proteins in the JAK-STAT signaling pathway. The JAK-STAT pathway is associated with various cellular processes, such as cell proliferation, cell death, and immune responses. Considering that the JAK-STAT pathway is involved in immunity, dysfunctional JAKs can cause autoimmune diseases, including rheumatoid arthritis. Therefore, several inhibitors have been developed to inhibit the function of JAKs in the case of abnormal JAK-STAT signaling. Emerging structural data on JAKs highlight the opportunities to design selective inhibitors that can overcome mutation-driven resistance. Therefore, novel JAK inhibitors need to be developed. In this review, we discuss the principal structural features of JAKs, focusing on the active site. In addition, we summarized the updated JAK inhibitors indicated for rheumatoid arthritis that are available in the pharmaceutical market. The binding modes of JAK inhibitors have also been described. Based on the structural analysis of JAKs and their inhibitors, we propose strategies for developing next-generation JAK inhibitors.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1716179"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lang Youth Medical Program: a 6-year blueprint for advancing educational attainment and achievement. 朗青年医学计划:促进教育成就的6年蓝图。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fmed.2025.1734475
Madeleine Ripple, Aysha Tabassum, Ronald R Sanchez, Isabelle Elton, J C Alejaldre, Mara Minguez

Introduction: Medical pipeline programs are one upstream approach to supporting student educational outcomes, a well-documented social determinant of health, through out-of-school time (OST) programming. The Lang Youth Medical Program (LYMP) is a 6-year, hospital-based model designed to immerse students ("Scholars") in a health science and clinical curriculum, fostering interest in health careers and providing educational support for youth in Northern Manhattan. LYMP stands out among other medical pipeline programs for its longitudinal model that targets students in middle school to enable comprehensive academic and career support. This paper aims to describe the structure, implementation, and outcomes of LYMP as a replicable model for improving educational outcomes among underrepresented youth.

Program overview: LYMP draws upon an urban hospital's existing resources and community partnerships to immerse Scholars in academic and clinical exploration. Across 6 years, Scholars receive a body-systems-based curriculum, clinical skills lessons, hospital tours, and annual summer internships, alongside rigorous support for high school and college applications, to prepare them for post-secondary pursuits. Simultaneously, Scholars' families receive parent workshops and connections to wraparound and counseling services as an additional dimension of support.

Outcomes: With a 92.6% retention rate across 16 graduating cohorts, approximately 93% of LYMP alumni pursue undergraduate degrees and one in five have pursued graduate degrees. Among alumni who have graduated college, 26% (n = 30) have returned to work full-time at the hosting hospital. Regardless of their professional or academic pathway, recent LYMP alumni scored 27% higher on standardized tests compared to their peers and report feeling well-equipped with professional and academic skills instrumental in their success.

Discussion: LYMP offers a scalable and replicable blueprint for healthcare institutions seeking to invest in educational equity and workforce development. Its modular curriculum, upstream intervention strategy, and integration within a hospital setting demonstrate how longitudinal, community-rooted programs can effectively support youth in achieving academic success, career readiness, and health literacy. Additionally, LYMP's novel approach has evolved to include socioemotional support and community resources to address the social determinants of health, providing Scholars with a holistic exposure to healthcare while continually meeting its mission to improve educational outcomes among Northern Manhattan youth.

简介:医疗管道项目是通过校外时间(OST)规划支持学生教育成果的一种上游方法,这是一个有充分证据的健康社会决定因素。朗青年医学项目(LYMP)是一个为期6年、以医院为基础的模式,旨在让学生(“学者”)沉浸在健康科学和临床课程中,培养他们对健康事业的兴趣,并为曼哈顿北部的年轻人提供教育支持。LYMP在其他医疗管道项目中脱颖而出,其纵向模型针对中学生提供全面的学术和职业支持。本文旨在描述LYMP的结构、实施和结果,将其作为改善代表性不足青年教育成果的可复制模式。项目概述:LYMP利用城市医院的现有资源和社区伙伴关系,使学者沉浸在学术和临床探索中。在6年的时间里,学生们将接受以身体系统为基础的课程,临床技能课程,医院参观和年度暑期实习,以及对高中和大学申请的严格支持,为他们的高等教育追求做好准备。同时,作为额外的支持维度,学者家庭接受家长研讨会和联系,以获得综合和咨询服务。结果:16届毕业生的保留率为92.6%,约93%的LYMP校友攻读本科学位,五分之一的校友攻读研究生学位。在大学毕业的校友中,26% (n = 30)回到主办医院全职工作。无论他们的专业或学术途径如何,最近的LYMP校友在标准化测试中的得分比同龄人高出27%,并报告说他们在成功的专业和学术技能方面都有很好的准备。讨论:LYMP为寻求投资教育公平和劳动力发展的医疗机构提供了可扩展和可复制的蓝图。它的模块化课程、上游干预策略以及在医院环境中的整合表明,纵向的、基于社区的项目如何有效地支持青少年取得学业成功、职业准备和健康素养。此外,LYMP的新方法已经发展到包括社会情感支持和社区资源,以解决健康的社会决定因素,为学者提供全面的医疗保健,同时不断满足其改善北曼哈顿青年教育成果的使命。
{"title":"The Lang Youth Medical Program: a 6-year blueprint for advancing educational attainment and achievement.","authors":"Madeleine Ripple, Aysha Tabassum, Ronald R Sanchez, Isabelle Elton, J C Alejaldre, Mara Minguez","doi":"10.3389/fmed.2025.1734475","DOIUrl":"https://doi.org/10.3389/fmed.2025.1734475","url":null,"abstract":"<p><strong>Introduction: </strong>Medical pipeline programs are one upstream approach to supporting student educational outcomes, a well-documented social determinant of health, through out-of-school time (OST) programming. The Lang Youth Medical Program (LYMP) is a 6-year, hospital-based model designed to immerse students (\"Scholars\") in a health science and clinical curriculum, fostering interest in health careers and providing educational support for youth in Northern Manhattan. LYMP stands out among other medical pipeline programs for its longitudinal model that targets students in middle school to enable comprehensive academic and career support. This paper aims to describe the structure, implementation, and outcomes of LYMP as a replicable model for improving educational outcomes among underrepresented youth.</p><p><strong>Program overview: </strong>LYMP draws upon an urban hospital's existing resources and community partnerships to immerse Scholars in academic and clinical exploration. Across 6 years, Scholars receive a body-systems-based curriculum, clinical skills lessons, hospital tours, and annual summer internships, alongside rigorous support for high school and college applications, to prepare them for post-secondary pursuits. Simultaneously, Scholars' families receive parent workshops and connections to wraparound and counseling services as an additional dimension of support.</p><p><strong>Outcomes: </strong>With a 92.6% retention rate across 16 graduating cohorts, approximately 93% of LYMP alumni pursue undergraduate degrees and one in five have pursued graduate degrees. Among alumni who have graduated college, 26% (<i>n</i> = 30) have returned to work full-time at the hosting hospital. Regardless of their professional or academic pathway, recent LYMP alumni scored 27% higher on standardized tests compared to their peers and report feeling well-equipped with professional and academic skills instrumental in their success.</p><p><strong>Discussion: </strong>LYMP offers a scalable and replicable blueprint for healthcare institutions seeking to invest in educational equity and workforce development. Its modular curriculum, upstream intervention strategy, and integration within a hospital setting demonstrate how longitudinal, community-rooted programs can effectively support youth in achieving academic success, career readiness, and health literacy. Additionally, LYMP's novel approach has evolved to include socioemotional support and community resources to address the social determinants of health, providing Scholars with a holistic exposure to healthcare while continually meeting its mission to improve educational outcomes among Northern Manhattan youth.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1734475"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a nomogram for predicting unfavorable treatment outcomes in patients with pulmonary tuberculosis and diabetes mellitus. 开发和验证预测肺结核和糖尿病患者不良治疗结果的nomogram。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1722736
Manman Liu, Tuantuan Li, Haiqing Liu, Fangfang Song, Lili Zhou, Wei Zhang

Objective: To develop and validate a clinical prediction model estimating individualized risk of unfavorable treatment outcomes in patients with pulmonary tuberculosis and diabetes mellitus (PTB-DM).

Methods: This retrospective study enrolled 110 inpatients with PTB-DM, categorized into favorable (n = 55) and unfavorable (n = 55) outcome groups. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to select the most relevant predictors from clinical and laboratory data. A multivariate logistic regression model was built based on these predictors to construct a nomogram. The model's performance was evaluated by its discrimination (Area Under the Curve, AUC), calibration (Hosmer-Lemeshow test and calibration curve), and clinical utility (Decision curve analysis). Internal validation was performed using bootstrap resampling (1,000 repetitions).

Results: Four variables were selected by LASSO regression for model construction: Age, Body Mass Index (BMI), pulmonary cavity, and the Glucose-to-Lymphocyte Ratio (GLR). The multivariate model confirmed these as independent risk factors. The nomogram demonstrated excellent discrimination, with an AUC of 0.885 (95% CI: 0.826-0.944) and a bootstrap-corrected AUC of 0.858. Good calibration was indicated by a non-significant Hosmer-Lemeshow test (P = 0.856). Decision curve analysis confirmed the model's clinical net benefit across a wide range of risk thresholds.

Conclusion: We developed and internally validated a nomogram that accurately predicts the risk of unfavorable outcomes in PTB-DM patients by integrating four readily available clinical parameters. This tool shows robust performance and holds promise for aiding clinicians in identifying high-risk individuals for personalized management strategies.

目的:建立并验证肺结核合并糖尿病(PTB-DM)患者不良治疗结果个体化风险的临床预测模型。方法:本回顾性研究纳入110例PTB-DM住院患者,分为预后良好组(n = 55)和预后不良组(n = 55)。最小绝对收缩和选择算子(LASSO)回归用于从临床和实验室数据中选择最相关的预测因子。在此基础上,建立多元逻辑回归模型,构建模态图。通过识别(曲线下面积,AUC)、校准(Hosmer-Lemeshow检验和校准曲线)和临床效用(决策曲线分析)来评价模型的性能。内部验证使用自举重采样(1000次重复)进行。结果:采用LASSO回归方法选取年龄、体重指数(BMI)、肺泡、葡萄糖淋巴细胞比(GLR) 4个变量进行模型构建。多变量模型证实了这些是独立的危险因素。nomogram表现出很好的辨别能力,AUC为0.885 (95% CI: 0.826-0.944), bootstrap校正的AUC为0.858。无显著性Hosmer-Lemeshow检验表明校准良好(P = 0.856)。决策曲线分析证实了该模型在广泛的风险阈值范围内的临床净收益。结论:我们开发并内部验证了通过整合四个现成的临床参数准确预测PTB-DM患者不良结局风险的nomogram。该工具表现出强大的性能,并有望帮助临床医生识别高风险个体的个性化管理策略。
{"title":"Development and validation of a nomogram for predicting unfavorable treatment outcomes in patients with pulmonary tuberculosis and diabetes mellitus.","authors":"Manman Liu, Tuantuan Li, Haiqing Liu, Fangfang Song, Lili Zhou, Wei Zhang","doi":"10.3389/fmed.2026.1722736","DOIUrl":"https://doi.org/10.3389/fmed.2026.1722736","url":null,"abstract":"<p><strong>Objective: </strong>To develop and validate a clinical prediction model estimating individualized risk of unfavorable treatment outcomes in patients with pulmonary tuberculosis and diabetes mellitus (PTB-DM).</p><p><strong>Methods: </strong>This retrospective study enrolled 110 inpatients with PTB-DM, categorized into favorable (<i>n</i> = 55) and unfavorable (<i>n</i> = 55) outcome groups. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to select the most relevant predictors from clinical and laboratory data. A multivariate logistic regression model was built based on these predictors to construct a nomogram. The model's performance was evaluated by its discrimination (Area Under the Curve, AUC), calibration (Hosmer-Lemeshow test and calibration curve), and clinical utility (Decision curve analysis). Internal validation was performed using bootstrap resampling (1,000 repetitions).</p><p><strong>Results: </strong>Four variables were selected by LASSO regression for model construction: Age, Body Mass Index (BMI), pulmonary cavity, and the Glucose-to-Lymphocyte Ratio (GLR). The multivariate model confirmed these as independent risk factors. The nomogram demonstrated excellent discrimination, with an AUC of 0.885 (95% CI: 0.826-0.944) and a bootstrap-corrected AUC of 0.858. Good calibration was indicated by a non-significant Hosmer-Lemeshow test (<i>P</i> = 0.856). Decision curve analysis confirmed the model's clinical net benefit across a wide range of risk thresholds.</p><p><strong>Conclusion: </strong>We developed and internally validated a nomogram that accurately predicts the risk of unfavorable outcomes in PTB-DM patients by integrating four readily available clinical parameters. This tool shows robust performance and holds promise for aiding clinicians in identifying high-risk individuals for personalized management strategies.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1722736"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based nursing strategies for the prevention and management of oral mucositis in hematopoietic stem cell transplantation patients. 以证据为基础的护理策略对造血干细胞移植患者口腔黏膜炎的预防和管理。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1737301
Min Cui

Hematopoietic stem cell transplantation (HSCT) is a cornerstone therapy for hematological malignancies, frequently complicated by treatment-related oral mucositis (OM). This complication leads to severe pain, nutritional compromise, heightened infection risk, and may result in treatment delays, prolonged hospitalization, and diminished long-term health-related quality of life. While clinical guidelines exist, a significant gap persists between evidence and practice, especially in the systematic and individualized application of preventive strategies. From an evidence-based nursing perspective, this perspective article proposes a comprehensive management framework. This framework integrates evidence synthesis, patient-specific risk assessment, dynamic monitoring, and multidisciplinary collaboration to align standardized interventions with personalized patient needs across all phases of HSCT. By synthesizing current evidence, analyzing practical challenges, and proposing a structured management pathway, this perspective article aims to guide clinical practice, inform future research, and ultimately improve care standards for OM in HSCT patients.

造血干细胞移植(HSCT)是血液系统恶性肿瘤的基础疗法,经常并发治疗相关性口腔黏膜炎(OM)。这种并发症导致严重疼痛、营养不良、感染风险增加,并可能导致治疗延误、住院时间延长和长期健康相关生活质量下降。虽然存在临床指南,但证据与实践之间仍然存在重大差距,特别是在系统和个性化应用预防策略方面。本文从循证护理的角度出发,提出了一个综合管理框架。该框架整合了证据综合、患者特异性风险评估、动态监测和多学科协作,使标准化干预与HSCT所有阶段的个性化患者需求保持一致。通过综合现有证据,分析现实挑战,提出结构化的管理路径,本文旨在指导临床实践,为未来的研究提供信息,最终提高HSCT患者OM的护理标准。
{"title":"Evidence-based nursing strategies for the prevention and management of oral mucositis in hematopoietic stem cell transplantation patients.","authors":"Min Cui","doi":"10.3389/fmed.2026.1737301","DOIUrl":"https://doi.org/10.3389/fmed.2026.1737301","url":null,"abstract":"<p><p>Hematopoietic stem cell transplantation (HSCT) is a cornerstone therapy for hematological malignancies, frequently complicated by treatment-related oral mucositis (OM). This complication leads to severe pain, nutritional compromise, heightened infection risk, and may result in treatment delays, prolonged hospitalization, and diminished long-term health-related quality of life. While clinical guidelines exist, a significant gap persists between evidence and practice, especially in the systematic and individualized application of preventive strategies. From an evidence-based nursing perspective, this perspective article proposes a comprehensive management framework. This framework integrates evidence synthesis, patient-specific risk assessment, dynamic monitoring, and multidisciplinary collaboration to align standardized interventions with personalized patient needs across all phases of HSCT. By synthesizing current evidence, analyzing practical challenges, and proposing a structured management pathway, this perspective article aims to guide clinical practice, inform future research, and ultimately improve care standards for OM in HSCT patients.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1737301"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of modified CT severity index by incorporating lymphocyte-to-monocyte ratio for early stratification in acute pancreatitis: a single-center validation study. 采用淋巴细胞/单核细胞比值优化改良CT严重程度指数,用于急性胰腺炎早期分层:一项单中心验证研究
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1752594
Li Zhang, Xiao Cao, Baochun Wang, Peng Ji

Background: Acute pancreatitis is a common digestive system emergency with heterogeneous clinical courses, and early accurate stratification is crucial for guiding treatment, improving prognosis, and reducing mortality. Existing scoring systems such as the Modified CT Severity Index (MCTSI) primarily rely on imaging features, but alone may not fully reflect inflammatory status, while inflammatory markers like the Lymphocyte-to-Monocyte Ratio (LMR) show potential in predicting disease severity; however, studies combining both are insufficient.

Objective: To investigate the value of integrating LMR with MCTSI to construct a new scoring system (MCTSI-LMR) for early stratification in acute pancreatitis, optimizing clinical predictive efficacy.

Methods: A total of 216 patients with acute pancreatitis admitted to Hefei Third People's Hospital from April 2022 to January 2025 were selected as the study subjects. All patients were divided into mild group (65 cases), moderately severe group (108 cases), and severe group (43 cases) according to the Atlanta classification criteria (2012 revision). All patients underwent abdominal CT scanning and complete blood count within 24 hours of admission to calculate MCTSI scores and LMR values. Using clinical outcomes as the gold standard, inter-group indicator differences and the diagnostic efficacy of the combined score were compared.

Results: Based on disease severity, the severe group had significantly lower LMR values than the mild and moderately severe groups (t = 125.473, P < 0.001) and higher MCTSI scores (t = 298.456, P < 0.001). The incidence of organ failure and mortality showed statistically significant differences between groups (χ2 = 98.765, P < 0.001; χ2 = 45.678, P < 0.001). Multivariate logistic regression analysis revealed that MCTSI score (Wald = 26.234, P < 0.001) and LMR (Wald = 41.156, P < 0.001) were independent predictors of severe acute pancreatitis. ROC curve analysis indicated that the MCTSI-LMR score had superior predictive performance compared to individual indicators (Z = 3.456-5.678, P < 0.05).

Conclusion: The application of the MCTSI-LMR score in early stratification of acute pancreatitis can significantly enhance predictive efficacy, with notable differences combining imaging and inflammatory markers, providing a reliable tool for clinical early intervention and worthy of promotion and application.

背景:急性胰腺炎是一种常见的消化系统急症,临床病程具有异质性,早期准确分层对指导治疗、改善预后、降低死亡率至关重要。现有的评分系统,如改进的CT严重程度指数(MCTSI)主要依赖于影像学特征,但单独可能不能完全反映炎症状态,而炎症标志物,如淋巴细胞与单核细胞比率(LMR),在预测疾病严重程度方面具有潜力;然而,将两者结合起来的研究是不够的。目的:探讨LMR与MCTSI结合构建新的评分系统(MCTSI-LMR)对急性胰腺炎早期分层的价值,优化临床预测效果。方法:选取合肥市第三人民医院2022年4月至2025年1月住院的急性胰腺炎患者216例作为研究对象。所有患者按照亚特兰大(2012年修订)分类标准分为轻度组(65例)、中度组(108例)和重度组(43例)。所有患者在入院24小时内进行腹部CT扫描和全血计数,计算MCTSI评分和LMR值。以临床结局为金标准,比较组间指标差异及综合评分的诊断效果。结果:重度组LMR值显著低于轻、中重度组(t = 125.473, P < 0.001), MCTSI评分显著高于轻、中重度组(t = 298.456, P < 0.001)。脏器功能衰竭发生率和病死率组间差异有统计学意义(χ2 = 98.765, P < 0.001; χ2 = 45.678, P < 0.001)。多因素logistic回归分析显示,MCTSI评分(Wald = 26.234, P < 0.001)和LMR (Wald = 41.156, P < 0.001)是严重急性胰腺炎的独立预测因子。ROC曲线分析显示MCTSI-LMR评分的预测效果优于单项指标(Z = 3.456 ~ 5.678, P < 0.05)。结论:应用MCTSI-LMR评分进行急性胰腺炎早期分层,可显著提高预测效果,结合影像学与炎症标志物,预测效果差异显著,为临床早期干预提供了可靠的工具,值得推广应用。
{"title":"Optimization of modified CT severity index by incorporating lymphocyte-to-monocyte ratio for early stratification in acute pancreatitis: a single-center validation study.","authors":"Li Zhang, Xiao Cao, Baochun Wang, Peng Ji","doi":"10.3389/fmed.2026.1752594","DOIUrl":"https://doi.org/10.3389/fmed.2026.1752594","url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis is a common digestive system emergency with heterogeneous clinical courses, and early accurate stratification is crucial for guiding treatment, improving prognosis, and reducing mortality. Existing scoring systems such as the Modified CT Severity Index (MCTSI) primarily rely on imaging features, but alone may not fully reflect inflammatory status, while inflammatory markers like the Lymphocyte-to-Monocyte Ratio (LMR) show potential in predicting disease severity; however, studies combining both are insufficient.</p><p><strong>Objective: </strong>To investigate the value of integrating LMR with MCTSI to construct a new scoring system (MCTSI-LMR) for early stratification in acute pancreatitis, optimizing clinical predictive efficacy.</p><p><strong>Methods: </strong>A total of 216 patients with acute pancreatitis admitted to Hefei Third People's Hospital from April 2022 to January 2025 were selected as the study subjects. All patients were divided into mild group (65 cases), moderately severe group (108 cases), and severe group (43 cases) according to the Atlanta classification criteria (2012 revision). All patients underwent abdominal CT scanning and complete blood count within 24 hours of admission to calculate MCTSI scores and LMR values. Using clinical outcomes as the gold standard, inter-group indicator differences and the diagnostic efficacy of the combined score were compared.</p><p><strong>Results: </strong>Based on disease severity, the severe group had significantly lower LMR values than the mild and moderately severe groups (<i>t</i> = 125.473, <i>P</i> < 0.001) and higher MCTSI scores (<i>t</i> = 298.456, <i>P</i> < 0.001). The incidence of organ failure and mortality showed statistically significant differences between groups (χ<sup>2</sup> = 98.765, <i>P</i> < 0.001; χ<sup>2</sup> = 45.678, <i>P</i> < 0.001). Multivariate logistic regression analysis revealed that MCTSI score (Wald = 26.234, <i>P</i> < 0.001) and LMR (Wald = 41.156, <i>P</i> < 0.001) were independent predictors of severe acute pancreatitis. ROC curve analysis indicated that the MCTSI-LMR score had superior predictive performance compared to individual indicators (<i>Z</i> = 3.456-5.678, <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The application of the MCTSI-LMR score in early stratification of acute pancreatitis can significantly enhance predictive efficacy, with notable differences combining imaging and inflammatory markers, providing a reliable tool for clinical early intervention and worthy of promotion and application.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1752594"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender-specific motivation for training in sexual history. 性史培训的具体性别动机。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fmed.2025.1734934
Nadja Platzer, Janine Utz, Maximilian Bailer, Nina Triebner, Gian-Marco Kersten, Johannes Kornhuber, Philipp Spitzer

Objective: Although sexual history taking is an essential component of a comprehensive medical history, it is often omitted in practice. To ensure competent assessment, this skill should be taught during medical school. However, interest in the topic-particularly among male students-remains limited. This study therefore aimed (1) to examine the impact of gender on students' motivation to learn sexual history taking and (2) to identify gender-independent factors. The findings are intended to inform teaching innovations that foster motivation in all students and, ultimately, improve the quality of patient care.

Methods: A cross-sectional online survey was conducted in the winter semester 2023/2024 among fifth- to eighth-semester medical students at Friedrich-Alexander University Erlangen-Nuremberg. The questionnaire comprised the Learning Self-Regulation Questionnaire (SRQ-L) and 11 self-developed items addressing potential influences on students' motivation to learn sexual history taking. Data were analyzed using t tests, ANOVA, regression, and mediation analyses.

Results: A total of 318 students participated (86 male, 232 female). Perceived relevance of the topic and the psychiatric clinic as the organizer of the elective course were significant predictors of motivation. Female students showed higher autonomous regulation than males [t (118.68) = -3.48, p < 0.001, d = 0.51] and rated the topic as more relevant [t (121.39) = -3.86, p < 0.001, d = 0.56]. Mediation analysis revealed that the gender effect on autonomous regulation was fully mediated by perceived relevance [indirect effect ab = 0.3231, 95% CI (0.160, 0.4996)].

Conclusion: Gender differences in motivation to attend a voluntary seminar on sexual history taking are explained by perceived relevance rather than biological sex. Relevance plays a central role in fostering autonomous motivation. Therefore, curricular strategies should emphasize the importance of sexual history taking to increase engagement across all genders. Integrating this topic into the compulsory curriculum may compensate for initial gender disparities and contribute to long-term improvements in medical interviewing and patient care.

目的:虽然性史是一个重要的组成部分,全面的病史,但在实践中往往被忽略。为了确保合格的评估,这项技能应该在医学院教授。然而,对这个话题的兴趣——尤其是男生——仍然有限。因此,本研究旨在(1)考察性别对学生学习性史动机的影响;(2)确定与性别无关的因素。研究结果旨在为教学创新提供信息,以培养所有学生的积极性,并最终提高患者护理的质量。方法:于2023/2024冬季学期对德国埃尔兰根-纽伦堡弗里德里希-亚历山大大学医学院五至八学期的学生进行横断面在线调查。问卷由《学习自我调节问卷》(SRQ-L)和11个自编项目组成,内容涉及对学生学习性史动机的潜在影响。数据分析采用t检验、方差分析、回归和中介分析。结果:共318名学生参与调查,其中男86名,女232名。主题的感知相关性和作为选修课程组织者的精神科诊所是动机的显著预测因子。女生比男生表现出更高的自主调节能力[t (118.68) = -3.48, p < 0.001, d = 0.51],并且认为话题更相关[t (121.39) = -3.86, p < 0.001, d = 0.56]。中介分析显示,性别对自主调节的影响完全由感知相关性介导[间接效应ab = 0.3231, 95% CI(0.160, 0.4996)]。结论:参加性史自愿研讨会的动机的性别差异是由感知相关性而不是生理性别来解释的。相关性在培养自主动机中起着核心作用。因此,课程策略应该强调性史学习的重要性,以增加所有性别的参与。将这一主题纳入必修课程可以弥补最初的性别差异,并有助于长期改善医疗面谈和病人护理。
{"title":"Gender-specific motivation for training in sexual history.","authors":"Nadja Platzer, Janine Utz, Maximilian Bailer, Nina Triebner, Gian-Marco Kersten, Johannes Kornhuber, Philipp Spitzer","doi":"10.3389/fmed.2025.1734934","DOIUrl":"https://doi.org/10.3389/fmed.2025.1734934","url":null,"abstract":"<p><strong>Objective: </strong>Although sexual history taking is an essential component of a comprehensive medical history, it is often omitted in practice. To ensure competent assessment, this skill should be taught during medical school. However, interest in the topic-particularly among male students-remains limited. This study therefore aimed (1) to examine the impact of gender on students' motivation to learn sexual history taking and (2) to identify gender-independent factors. The findings are intended to inform teaching innovations that foster motivation in all students and, ultimately, improve the quality of patient care.</p><p><strong>Methods: </strong>A cross-sectional online survey was conducted in the winter semester 2023/2024 among fifth- to eighth-semester medical students at Friedrich-Alexander University Erlangen-Nuremberg. The questionnaire comprised the Learning Self-Regulation Questionnaire (SRQ-L) and 11 self-developed items addressing potential influences on students' motivation to learn sexual history taking. Data were analyzed using <i>t</i> tests, ANOVA, regression, and mediation analyses.</p><p><strong>Results: </strong>A total of 318 students participated (86 male, 232 female). Perceived relevance of the topic and the psychiatric clinic as the organizer of the elective course were significant predictors of motivation. Female students showed higher autonomous regulation than males [<i>t</i> (118.68) = -3.48, <i>p</i> < 0.001, d = 0.51] and rated the topic as more relevant [<i>t</i> (121.39) = -3.86, <i>p</i> < 0.001, <i>d</i> = 0.56]. Mediation analysis revealed that the gender effect on autonomous regulation was fully mediated by perceived relevance [indirect effect ab = 0.3231, 95% CI (0.160, 0.4996)].</p><p><strong>Conclusion: </strong>Gender differences in motivation to attend a voluntary seminar on sexual history taking are explained by perceived relevance rather than biological sex. Relevance plays a central role in fostering autonomous motivation. Therefore, curricular strategies should emphasize the importance of sexual history taking to increase engagement across all genders. Integrating this topic into the compulsory curriculum may compensate for initial gender disparities and contribute to long-term improvements in medical interviewing and patient care.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1734934"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Humanized anti-CD33 CAR-T cells and antibody-drug conjugates for targeted therapy in acute myeloid leukemia. 人源化抗cd33 CAR-T细胞和抗体-药物偶联物用于急性髓性白血病的靶向治疗。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1691417
Lijun Chen, Honghong Duan, Chunling Huang, Yajing Xu, Zitong Wang, Huibin Huang

Background: Acute myeloid leukemia (AML) is a malignant disorder originating from myeloid hematopoietic stem and progenitor cells. Despite the availability of current treatment options, a significant number of patients fail to achieve complete remission after initial chemotherapy. CD33, a transmembrane protein highly expressed on AML cells, serves as a promising therapeutic target. This study aimed to develop and evaluate chimeric antigen receptor T cells (CAR-T) and antibody-drug conjugates (ADC) based on humanized antibodies, specifically targeting CD33, to assess their potential efficacy against AML.

Methods: Monoclonal antibodies specific to human CD33 were generated by immunizing mice and then humanized. These humanized antibodies were then used to construct CAR-T cells and ADCs, and their cytotoxic properties were evaluated both in vitro and in vivo. In the in vivo experiments, mice bearing Molm13-Luciferase tumor cells were assigned to different treatment groups and were administered with saline, Gemtuzumab-MMAE, or Clone3HM-MMAE.

Results: The in vitro experiments revealed that several antibody clones, including Clone2HM, Clone3HM, Clone5HM, Clone6HM, and Clone7HM, displayed strong cytotoxic effects against Molm13-Luciferase tumor cells when conjugated with MMAE, outperforming the positive control antibody Gemtuzumab-MMAE. In the in vivo studies, mice treated with Clone3HM-MMAE showed a significant reduction in tumor signals, which nearly disappeared in the latter stages of the experiment. This led to a substantially longer survival time compared to other groups. Additionally, the body weight of mice in all treatment groups remained stable throughout the treatment period, indicating a favorable safety profile.

Conclusion: The CAR-T cells and ADCs developed in this study, based on humanized antibodies, showed significant anti-tumor efficacy in the AML model. Clone3HM-MMAE, in particular, demonstrated excellent anti-tumor activity along with a strong safety profile. These results strongly support the further development of targeted therapeutic strategies for AML.

背景:急性髓系白血病(Acute myeloid leukemia, AML)是一种起源于髓系造血干细胞和祖细胞的恶性疾病。尽管目前的治疗方案是可行的,但相当多的患者在初始化疗后未能达到完全缓解。CD33是一种在AML细胞上高度表达的跨膜蛋白,是一种很有希望的治疗靶点。本研究旨在开发和评估嵌合抗原受体T细胞(CAR-T)和基于人源化抗体的抗体-药物偶联物(ADC),特异性靶向CD33,以评估其治疗AML的潜在疗效。方法:通过免疫小鼠制备人CD33特异性单克隆抗体,然后人源化。然后将这些人源化抗体用于构建CAR-T细胞和adc,并在体外和体内评估其细胞毒性。在体内实验中,将携带molm13 -荧光素酶肿瘤细胞的小鼠分为不同的治疗组,分别给予生理盐水、Gemtuzumab-MMAE或Clone3HM-MMAE。结果:体外实验显示,Clone2HM、Clone3HM、Clone5HM、Clone6HM和Clone7HM等抗体克隆与MMAE结合后,对Molm13-Luciferase肿瘤细胞表现出较强的细胞毒作用,优于阳性对照抗体Gemtuzumab-MMAE。在体内研究中,使用Clone3HM-MMAE处理的小鼠肿瘤信号明显减少,在实验后期几乎消失。与其他群体相比,这导致了更长的生存时间。此外,所有治疗组小鼠的体重在整个治疗期间保持稳定,表明良好的安全性。结论:本研究基于人源化抗体开发的CAR-T细胞和adc在AML模型中具有明显的抗肿瘤作用。特别是Clone3HM-MMAE,具有良好的抗肿瘤活性和较强的安全性。这些结果有力地支持了AML靶向治疗策略的进一步发展。
{"title":"Humanized anti-CD33 CAR-T cells and antibody-drug conjugates for targeted therapy in acute myeloid leukemia.","authors":"Lijun Chen, Honghong Duan, Chunling Huang, Yajing Xu, Zitong Wang, Huibin Huang","doi":"10.3389/fmed.2026.1691417","DOIUrl":"https://doi.org/10.3389/fmed.2026.1691417","url":null,"abstract":"<p><strong>Background: </strong>Acute myeloid leukemia (AML) is a malignant disorder originating from myeloid hematopoietic stem and progenitor cells. Despite the availability of current treatment options, a significant number of patients fail to achieve complete remission after initial chemotherapy. CD33, a transmembrane protein highly expressed on AML cells, serves as a promising therapeutic target. This study aimed to develop and evaluate chimeric antigen receptor T cells (CAR-T) and antibody-drug conjugates (ADC) based on humanized antibodies, specifically targeting CD33, to assess their potential efficacy against AML.</p><p><strong>Methods: </strong>Monoclonal antibodies specific to human CD33 were generated by immunizing mice and then humanized. These humanized antibodies were then used to construct CAR-T cells and ADCs, and their cytotoxic properties were evaluated both <i>in vitro</i> and <i>in vivo</i>. In the in vivo experiments, mice bearing Molm13-Luciferase tumor cells were assigned to different treatment groups and were administered with saline, Gemtuzumab-MMAE, or Clone3HM-MMAE.</p><p><strong>Results: </strong>The <i>in vitro</i> experiments revealed that several antibody clones, including Clone2HM, Clone3HM, Clone5HM, Clone6HM, and Clone7HM, displayed strong cytotoxic effects against Molm13-Luciferase tumor cells when conjugated with MMAE, outperforming the positive control antibody Gemtuzumab-MMAE. In the <i>in vivo</i> studies, mice treated with Clone3HM-MMAE showed a significant reduction in tumor signals, which nearly disappeared in the latter stages of the experiment. This led to a substantially longer survival time compared to other groups. Additionally, the body weight of mice in all treatment groups remained stable throughout the treatment period, indicating a favorable safety profile.</p><p><strong>Conclusion: </strong>The CAR-T cells and ADCs developed in this study, based on humanized antibodies, showed significant anti-tumor efficacy in the AML model. Clone3HM-MMAE, in particular, demonstrated excellent anti-tumor activity along with a strong safety profile. These results strongly support the further development of targeted therapeutic strategies for AML.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1691417"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12884322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vibrio vulnificus infection caused by a hand puncture wound from seafood: a case report. 手部海鲜刺伤致创伤弧菌感染1例。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1747587
Lin Zhao, Peiting Lin, Tianyi Liu, Weidong Liu, Peilin Xie

Vibrio vulnificus infection is characterized by rapid progression and poor prognosis, which can lead to disability or death without timely intervention. In some cities or countries where the incidence of V. vulnificus infection is not high, it is easy to cause misdiagnosis and delay the treatment of the disease. This case showed a 42-year-old man from a non-coastal area in China who accidentally stabbed his right hand while handling seafood 1 day earlier. He developed significant local redness, swelling, pain, and systemic symptoms. When the patient visits the doctor, the doctor makes an accurate initial diagnosis based on the patient's medical history and clinical manifestations. Effective antibiotic combination treatment is given before the feedback of bacterial culture results. Fasciotomy is immediately performed when there are signs of progression of osteofascial compartment syndrome. Finally, the patient's right hand and right forearm were preserved.

创伤弧菌感染的特点是进展迅速,预后差,如果不及时干预,可导致残疾或死亡。在一些创伤弧菌感染发病率不高的城市或国家,容易造成误诊,耽误疾病的治疗。该病例显示一名来自中国非沿海地区的42岁男子在1天前处理海鲜时意外刺伤右手。他出现明显的局部红肿、疼痛和全身症状。当患者就诊时,医生根据患者的病史和临床表现做出准确的初步诊断。在细菌培养结果反馈前给予有效的抗生素联合治疗。当有骨筋膜室综合征进展的迹象时,立即进行筋膜切开术。最后,保留患者的右手和右前臂。
{"title":"<i>Vibrio vulnificus</i> infection caused by a hand puncture wound from seafood: a case report.","authors":"Lin Zhao, Peiting Lin, Tianyi Liu, Weidong Liu, Peilin Xie","doi":"10.3389/fmed.2026.1747587","DOIUrl":"https://doi.org/10.3389/fmed.2026.1747587","url":null,"abstract":"<p><p><i>Vibrio vulnificus</i> infection is characterized by rapid progression and poor prognosis, which can lead to disability or death without timely intervention. In some cities or countries where the incidence of <i>V. vulnificus</i> infection is not high, it is easy to cause misdiagnosis and delay the treatment of the disease. This case showed a 42-year-old man from a non-coastal area in China who accidentally stabbed his right hand while handling seafood 1 day earlier. He developed significant local redness, swelling, pain, and systemic symptoms. When the patient visits the doctor, the doctor makes an accurate initial diagnosis based on the patient's medical history and clinical manifestations. Effective antibiotic combination treatment is given before the feedback of bacterial culture results. Fasciotomy is immediately performed when there are signs of progression of osteofascial compartment syndrome. Finally, the patient's right hand and right forearm were preserved.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1747587"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ICCTUS score - Inspiration, Circulation and Consciousness predicting the Threat for an Unfavorable Outcome after SAH. ICCTUS评分-吸气、循环和意识预测SAH后不良后果的威胁。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1743482
Elena Kurz, Verena Fassl, Alicia Schulze, Darius Kalasauskas, Florian Ringel, Axel Neulen

Background: We previously developed a novel score derived from the Sequential Organ Failure Assessment score and demonstrated its ability to predict delayed cerebral ischemia-associated infarctions following spontaneous subarachnoid hemorrhage. In the current study, we investigated whether the new score (ICCTUS score) can predict neurological outcome.

Methods: We retrospectively evaluated all SAH patients in our neurosurgical ICU during a 10-year period. Patients were included if clinical data were available to determine SOFA and ICCTUS scores. Outcome was objectified by the modified Rankin Scale (mRS) after 6 months. Every parameter of the SOFA score was graded for its predictive value and combinations were tested using ROC analysis.

Results: 430 patients fulfilled the inclusion criteria (68.14% female, mean age: 56.8 ± 12.5 years). Median SOFA and ICCTUS scores were 5. The SOFA score had an AUC of 0.76 for prediction of unfavorable outcome. In comparison, the WFNS achieved an AUC of 0.71, and the HH an AUC of 0.64. For the ICCTUS score, which is based exclusively on the subscores rating the central nervous system, the cardiovascular system, and the respiratory system the AUC was at 0.8 with a sensitivity of 0.74, a specificity of 0.74, a PPV of 0.83 and a NPV of 0.62. The Youden index was 0.48 (cut-off ≥3 points).

Conclusion: The ICCTUS score was at least equal or superior to the established scores in predicting unfavorable outcome after SAH. The score could be implemented as an additional tool in multimodal diagnostics to identify patients at high risk.

背景:我们之前从序贯器官衰竭评估评分中开发了一种新的评分,并证明了其预测自发性蛛网膜下腔出血后延迟性脑缺血相关梗死的能力。在目前的研究中,我们研究了新的评分(ICCTUS评分)是否可以预测神经预后。方法:我们回顾性评估了我院神经外科ICU 10年间收治的所有SAH患者。如果有临床资料可以确定SOFA和ICCTUS评分,则纳入患者。6 个月后用改良Rankin量表(mRS)客观评价结果。对SOFA评分各参数的预测价值进行分级,并采用ROC分析进行组合检验。结果:430例患者符合纳入标准,其中女性占68.14%,平均年龄:56.8 ± 12.5 岁。SOFA和ICCTUS评分中位数为5分。SOFA评分预测不良结果的AUC为0.76。相比之下,WFNS的AUC为0.71,HH的AUC为0.64。ICCTUS评分完全基于对中枢神经系统、心血管系统和呼吸系统的评分,AUC为0.8,敏感性为0.74,特异性为0.74,PPV为0.83,NPV为0.62。约登指数为0.48(临界值≥3点)。结论:在预测SAH后不良预后方面,ICCTUS评分至少等于或优于现有评分。该评分可以作为多模式诊断的附加工具来实施,以识别高风险患者。
{"title":"ICCTUS score - Inspiration, Circulation and Consciousness predicting the Threat for an Unfavorable Outcome after SAH.","authors":"Elena Kurz, Verena Fassl, Alicia Schulze, Darius Kalasauskas, Florian Ringel, Axel Neulen","doi":"10.3389/fmed.2026.1743482","DOIUrl":"https://doi.org/10.3389/fmed.2026.1743482","url":null,"abstract":"<p><strong>Background: </strong>We previously developed a novel score derived from the Sequential Organ Failure Assessment score and demonstrated its ability to predict delayed cerebral ischemia-associated infarctions following spontaneous subarachnoid hemorrhage. In the current study, we investigated whether the new score (ICCTUS score) can predict neurological outcome.</p><p><strong>Methods: </strong>We retrospectively evaluated all SAH patients in our neurosurgical ICU during a 10-year period. Patients were included if clinical data were available to determine SOFA and ICCTUS scores. Outcome was objectified by the modified Rankin Scale (mRS) after 6 months. Every parameter of the SOFA score was graded for its predictive value and combinations were tested using ROC analysis.</p><p><strong>Results: </strong>430 patients fulfilled the inclusion criteria (68.14% female, mean age: 56.8 ± 12.5 years). Median SOFA and ICCTUS scores were 5. The SOFA score had an AUC of 0.76 for prediction of unfavorable outcome. In comparison, the WFNS achieved an AUC of 0.71, and the HH an AUC of 0.64. For the ICCTUS score, which is based exclusively on the subscores rating the central nervous system, the cardiovascular system, and the respiratory system the AUC was at 0.8 with a sensitivity of 0.74, a specificity of 0.74, a PPV of 0.83 and a NPV of 0.62. The Youden index was 0.48 (cut-off ≥3 points).</p><p><strong>Conclusion: </strong>The ICCTUS score was at least equal or superior to the established scores in predicting unfavorable outcome after SAH. The score could be implemented as an additional tool in multimodal diagnostics to identify patients at high risk.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1743482"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture for chemotherapy-induced hemifacial spasm: a case report. 电针治疗化疗致面肌痉挛1例。
IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fmed.2026.1700524
Xin Tan, Wenlong Bao, Dehou Deng, Chao Lu, Weiji Chen

Introduction: Hemifacial spasm (HFS) is a neurological disorder characterized by involuntary, paroxysmal twitching of facial muscles, primarily presenting as sudden and recurrent contractions on one side of the face. This case report described the therapeutic effect of electroacupuncture (EA) in a cervical cancer patient who developed HFS following chemotherapy.

Case description: A 60-year-old female patient with cervical cancer developed severe involuntary twitching of the right facial muscles following chemotherapy, which significantly impaired her daily activities. The patient was diagnosed with HFS and was introduced to the acupuncture department to receive EA treatment. Following 15 sessions of EA treatment, the patient's HFS symptoms improved significantly, with complete resolution of facial muscle twitching.

Conclusion: The case suggests that EA may be an effective alternative treatment for chemotherapy-induced HFS.

面肌痉挛(HFS)是一种神经系统疾病,其特征是面部肌肉不自主、阵发性抽搐,主要表现为面部一侧突然反复收缩。本病例报告描述了电针(EA)治疗宫颈癌患者化疗后HFS的疗效。病例描述:一名60岁女性宫颈癌患者在化疗后出现严重的右侧面部肌肉不自主抽搐,严重影响了她的日常活动。患者被诊断为HFS,并被介绍到针灸科接受EA治疗。经过15次EA治疗后,患者的HFS症状明显改善,面部肌肉抽搐完全消失。结论:该病例提示EA可能是化疗诱导的HFS的有效替代治疗方法。
{"title":"Electroacupuncture for chemotherapy-induced hemifacial spasm: a case report.","authors":"Xin Tan, Wenlong Bao, Dehou Deng, Chao Lu, Weiji Chen","doi":"10.3389/fmed.2026.1700524","DOIUrl":"https://doi.org/10.3389/fmed.2026.1700524","url":null,"abstract":"<p><strong>Introduction: </strong>Hemifacial spasm (HFS) is a neurological disorder characterized by involuntary, paroxysmal twitching of facial muscles, primarily presenting as sudden and recurrent contractions on one side of the face. This case report described the therapeutic effect of electroacupuncture (EA) in a cervical cancer patient who developed HFS following chemotherapy.</p><p><strong>Case description: </strong>A 60-year-old female patient with cervical cancer developed severe involuntary twitching of the right facial muscles following chemotherapy, which significantly impaired her daily activities. The patient was diagnosed with HFS and was introduced to the acupuncture department to receive EA treatment. Following 15 sessions of EA treatment, the patient's HFS symptoms improved significantly, with complete resolution of facial muscle twitching.</p><p><strong>Conclusion: </strong>The case suggests that EA may be an effective alternative treatment for chemotherapy-induced HFS.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1700524"},"PeriodicalIF":3.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1